 | • レポートコード：D0804-00850 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、101ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、AT1受容体拮抗薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。AT1受容体拮抗薬の種類別市場規模（バルサルタン、テルミサルタン、ロサルタン、イルベサルタン、アジルサルタン、オルメサルタン）、用途別市場規模（高血圧、心血管疾患、腎臓病、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Bristol-Myers Squibb、Astra Zeneca、Novartis、Sanofi、Merck、GSK、Eli Lilly、Jhonson and Johnson、Bayer、Teva Pharmaceutical ・地域別グローバル市場分析 2015年-2020年 ・AT1受容体拮抗薬の北米市場（アメリカ、カナダ、メキシコ） ・AT1受容体拮抗薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・AT1受容体拮抗薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・AT1受容体拮抗薬の南米市場（ブラジル、アルゼンチン） ・AT1受容体拮抗薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：バルサルタン、テルミサルタン、ロサルタン、イルベサルタン、アジルサルタン、オルメサルタン ・用途別分析：高血圧、心血管疾患、腎臓病、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global AT1 Receptor Antagonists market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The AT1 Receptor Antagonists market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
AT1 Receptor Antagonists market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, AT1 Receptor Antagonists market has been segmented into
Valsartan
Telmisartan
Losartan
Irbesartan
Azilsartan
Olmesartan
By Application, AT1 Receptor Antagonists has been segmented into:
Hypertension
Cardiovascular Diseases
Kidney Diseases
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global AT1 Receptor Antagonists market presented in the report. This section sheds light on the sales growth of different regional and country-level AT1 Receptor Antagonists markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global AT1 Receptor Antagonists market.
The report offers in-depth assessment of the growth and other aspects of the AT1 Receptor Antagonists market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and AT1 Receptor Antagonists Market Share Analysis
AT1 Receptor Antagonists competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, AT1 Receptor Antagonists sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the AT1 Receptor Antagonists sales, revenue and market share for each player covered in this report.
The major players covered in AT1 Receptor Antagonists are:
Pfizer
Bristol-Myers Squibb
Astra Zeneca
Novartis
Sanofi
Merck
GSK
Eli Lilly
Jhonson and Johnson
Bayer
Teva Pharmaceutical
Among other players domestic and global, AT1 Receptor Antagonists market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe AT1 Receptor Antagonists product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of AT1 Receptor Antagonists, with price, sales, revenue and global market share of AT1 Receptor Antagonists in 2018 and 2019.
Chapter 3, the AT1 Receptor Antagonists competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the AT1 Receptor Antagonists breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, AT1 Receptor Antagonists market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe AT1 Receptor Antagonists sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 AT1 Receptor Antagonists Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global AT1 Receptor Antagonists Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Valsartan
1.2.3 Telmisartan
1.2.4 Losartan
1.2.5 Irbesartan
1.2.6 Azilsartan
1.2.7 Olmesartan
1.3 Market Analysis by Application
1.3.1 Overview: Global AT1 Receptor Antagonists Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hypertension
1.3.3 Cardiovascular Diseases
1.3.4 Kidney Diseases
1.3.5 Other
1.4 Overview of Global AT1 Receptor Antagonists Market
1.4.1 Global AT1 Receptor Antagonists Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bristol-Myers Squibb
2.2.1 Bristol-Myers Squibb Details
2.2.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bristol-Myers Squibb SWOT Analysis
2.2.4 Bristol-Myers Squibb Product and Services
2.2.5 Bristol-Myers Squibb AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Astra Zeneca
2.3.1 Astra Zeneca Details
2.3.2 Astra Zeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Astra Zeneca SWOT Analysis
2.3.4 Astra Zeneca Product and Services
2.3.5 Astra Zeneca AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sanofi SWOT Analysis
2.5.4 Sanofi Product and Services
2.5.5 Sanofi AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck SWOT Analysis
2.6.4 Merck Product and Services
2.6.5 Merck AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 GSK
2.7.1 GSK Details
2.7.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 GSK SWOT Analysis
2.7.4 GSK Product and Services
2.7.5 GSK AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Eli Lilly
2.8.1 Eli Lilly Details
2.8.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Eli Lilly SWOT Analysis
2.8.4 Eli Lilly Product and Services
2.8.5 Eli Lilly AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Jhonson and Johnson
2.9.1 Jhonson and Johnson Details
2.9.2 Jhonson and Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Jhonson and Johnson SWOT Analysis
2.9.4 Jhonson and Johnson Product and Services
2.9.5 Jhonson and Johnson AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bayer
2.10.1 Bayer Details
2.10.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bayer SWOT Analysis
2.10.4 Bayer Product and Services
2.10.5 Bayer AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Teva Pharmaceutical
2.11.1 Teva Pharmaceutical Details
2.11.2 Teva Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Teva Pharmaceutical SWOT Analysis
2.11.4 Teva Pharmaceutical Product and Services
2.11.5 Teva Pharmaceutical AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global AT1 Receptor Antagonists Sales and Market Share by Manufacturer (2018-2019)
3.2 Global AT1 Receptor Antagonists Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 AT1 Receptor Antagonists Manufacturer Market Share in 2019
3.3.2 Top 6 AT1 Receptor Antagonists Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global AT1 Receptor Antagonists Sales, Revenue and Market Share by Regions
4.1.1 Global AT1 Receptor Antagonists Sales and Market Share by Regions (2015-2020)
4.1.2 Global AT1 Receptor Antagonists Revenue and Market Share by Regions (2015-2020)
4.2 North America AT1 Receptor Antagonists Sales and Growth Rate (2015-2020)
4.3 Europe AT1 Receptor Antagonists Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific AT1 Receptor Antagonists Sales and Growth Rate (2015-2020)
4.5 South America AT1 Receptor Antagonists Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa AT1 Receptor Antagonists Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America AT1 Receptor Antagonists Sales, Revenue and Market Share by Country
5.1.1 North America AT1 Receptor Antagonists Sales and Market Share by Country (2015-2020)
5.1.2 North America AT1 Receptor Antagonists Revenue and Market Share by Country (2015-2020)
5.2 United States AT1 Receptor Antagonists Sales and Growth Rate (2015-2020)
5.3 Canada AT1 Receptor Antagonists Sales and Growth Rate (2015-2020)
5.4 Mexico AT1 Receptor Antagonists Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe AT1 Receptor Antagonists Sales, Revenue and Market Share by Country
6.1.1 Europe AT1 Receptor Antagonists Sales and Market Share by Country (2015-2020)
6.1.2 Europe AT1 Receptor Antagonists Revenue and Market Share by Country (2015-2020)
6.2 Germany AT1 Receptor Antagonists Sales and Growth Rate (2015-2020)
6.3 UK AT1 Receptor Antagonists Sales and Growth Rate (2015-2020)
6.4 France AT1 Receptor Antagonists Sales and Growth Rate (2015-2020)
6.5 Russia AT1 Receptor Antagonists Sales and Growth Rate (2015-2020)
6.6 Italy AT1 Receptor Antagonists Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific AT1 Receptor Antagonists Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific AT1 Receptor Antagonists Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific AT1 Receptor Antagonists Revenue and Market Share by Regions (2015-2020)
7.2 China AT1 Receptor Antagonists Sales and Growth Rate (2015-2020)
7.3 Japan AT1 Receptor Antagonists Sales and Growth Rate (2015-2020)
7.4 Korea AT1 Receptor Antagonists Sales and Growth Rate (2015-2020)
7.5 India AT1 Receptor Antagonists Sales and Growth Rate (2015-2020)
7.6 Southeast Asia AT1 Receptor Antagonists Sales and Growth Rate (2015-2020)
7.7 Australia AT1 Receptor Antagonists Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America AT1 Receptor Antagonists Sales, Revenue and Market Share by Country
8.1.1 South America AT1 Receptor Antagonists Sales and Market Share by Country (2015-2020)
8.1.2 South America AT1 Receptor Antagonists Revenue and Market Share by Country (2015-2020)
8.2 Brazil AT1 Receptor Antagonists Sales and Growth Rate (2015-2020)
8.3 Argentina AT1 Receptor Antagonists Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa AT1 Receptor Antagonists Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa AT1 Receptor Antagonists Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa AT1 Receptor Antagonists Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia AT1 Receptor Antagonists Sales and Growth Rate (2015-2020)
9.3 Turkey AT1 Receptor Antagonists Sales and Growth Rate (2015-2020)
9.4 Egypt AT1 Receptor Antagonists Sales and Growth Rate (2015-2020)
9.5 South Africa AT1 Receptor Antagonists Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global AT1 Receptor Antagonists Sales and Market Share by Type (2015-2020)
10.2 Global AT1 Receptor Antagonists Revenue and Market Share by Type (2015-2020)
10.3 Global AT1 Receptor Antagonists Price by Type (2015-2020)
11 Global AT1 Receptor Antagonists Market Segment by Application
11.1 Global AT1 Receptor Antagonists Sales Market Share by Application (2015-2020)
11.2 Global AT1 Receptor Antagonists Revenue Market Share by Application (2015-2020)
11.3 Global AT1 Receptor Antagonists Price by Application (2015-2020)
12 Market Forecast
12.1 Global AT1 Receptor Antagonists Sales, Revenue and Growth Rate (2021-2025)
12.2 AT1 Receptor Antagonists Market Forecast by Regions (2021-2025)
12.2.1 North America AT1 Receptor Antagonists Market Forecast (2021-2025)
12.2.2 Europe AT1 Receptor Antagonists Market Forecast (2021-2025)
12.2.3 Asia-Pacific AT1 Receptor Antagonists Market Forecast (2021-2025)
12.2.4 South America AT1 Receptor Antagonists Market Forecast (2021-2025)
12.2.5 Middle East & Africa AT1 Receptor Antagonists Market Forecast (2021-2025)
12.3 AT1 Receptor Antagonists Market Forecast by Type (2021-2025)
12.3.1 Global AT1 Receptor Antagonists Sales Forecast by Type (2021-2025)
12.3.2 Global AT1 Receptor Antagonists Market Share Forecast by Type (2021-2025)
12.4 AT1 Receptor Antagonists Market Forecast by Application (2021-2025)
12.4.1 Global AT1 Receptor Antagonists Sales Forecast by Application (2021-2025)
12.4.2 Global AT1 Receptor Antagonists Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global AT1 Receptor Antagonists Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of AT1 Receptor Antagonists by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global AT1 Receptor Antagonists Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer AT1 Receptor Antagonists Major Business
Table 9. Pfizer AT1 Receptor Antagonists Total Revenue (USD Million) (2017-2018)
Table 10. Pfizer SWOT Analysis
Table 11. Pfizer AT1 Receptor Antagonists Product and Services
Table 12. Pfizer AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 14. Bristol-Myers Squibb AT1 Receptor Antagonists Major Business
Table 15. Bristol-Myers Squibb AT1 Receptor Antagonists Total Revenue (USD Million) (2017-2018)
Table 16. Bristol-Myers Squibb SWOT Analysis
Table 17. Bristol-Myers Squibb AT1 Receptor Antagonists Product and Services
Table 18. Bristol-Myers Squibb AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Astra Zeneca Basic Information, Manufacturing Base and Competitors
Table 20. Astra Zeneca AT1 Receptor Antagonists Major Business
Table 21. Astra Zeneca AT1 Receptor Antagonists Total Revenue (USD Million) (2017-2018)
Table 22. Astra Zeneca SWOT Analysis
Table 23. Astra Zeneca AT1 Receptor Antagonists Product and Services
Table 24. Astra Zeneca AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Novartis Basic Information, Manufacturing Base and Competitors
Table 26. Novartis AT1 Receptor Antagonists Major Business
Table 27. Novartis AT1 Receptor Antagonists Total Revenue (USD Million) (2017-2018)
Table 28. Novartis SWOT Analysis
Table 29. Novartis AT1 Receptor Antagonists Product and Services
Table 30. Novartis AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Sanofi Basic Information, Manufacturing Base and Competitors
Table 32. Sanofi AT1 Receptor Antagonists Major Business
Table 33. Sanofi AT1 Receptor Antagonists Total Revenue (USD Million) (2017-2018)
Table 34. Sanofi SWOT Analysis
Table 35. Sanofi AT1 Receptor Antagonists Product and Services
Table 36. Sanofi AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Merck Basic Information, Manufacturing Base and Competitors
Table 38. Merck AT1 Receptor Antagonists Major Business
Table 39. Merck AT1 Receptor Antagonists Total Revenue (USD Million) (2017-2018)
Table 40. Merck SWOT Analysis
Table 41. Merck AT1 Receptor Antagonists Product and Services
Table 42. Merck AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. GSK Basic Information, Manufacturing Base and Competitors
Table 44. GSK AT1 Receptor Antagonists Major Business
Table 45. GSK AT1 Receptor Antagonists Total Revenue (USD Million) (2017-2018)
Table 46. GSK SWOT Analysis
Table 47. GSK AT1 Receptor Antagonists Product and Services
Table 48. GSK AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 50. Eli Lilly AT1 Receptor Antagonists Major Business
Table 51. Eli Lilly AT1 Receptor Antagonists Total Revenue (USD Million) (2017-2018)
Table 52. Eli Lilly SWOT Analysis
Table 53. Eli Lilly AT1 Receptor Antagonists Product and Services
Table 54. Eli Lilly AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Jhonson and Johnson Basic Information, Manufacturing Base and Competitors
Table 56. Jhonson and Johnson AT1 Receptor Antagonists Major Business
Table 57. Jhonson and Johnson AT1 Receptor Antagonists Total Revenue (USD Million) (2017-2018)
Table 58. Jhonson and Johnson SWOT Analysis
Table 59. Jhonson and Johnson AT1 Receptor Antagonists Product and Services
Table 60. Jhonson and Johnson AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Bayer Basic Information, Manufacturing Base and Competitors
Table 62. Bayer AT1 Receptor Antagonists Major Business
Table 63. Bayer AT1 Receptor Antagonists Total Revenue (USD Million) (2017-2018)
Table 64. Bayer SWOT Analysis
Table 65. Bayer AT1 Receptor Antagonists Product and Services
Table 66. Bayer AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Teva Pharmaceutical AT1 Receptor Antagonists Major Business
Table 69. Teva Pharmaceutical AT1 Receptor Antagonists Total Revenue (USD Million) (2017-2018)
Table 70. Teva Pharmaceutical SWOT Analysis
Table 71. Teva Pharmaceutical AT1 Receptor Antagonists Product and Services
Table 72. Teva Pharmaceutical AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Global AT1 Receptor Antagonists Sales by Manufacturer (2018-2019) (K Units)
Table 74. Global AT1 Receptor Antagonists Revenue by Manufacturer (2018-2019) (USD Million)
Table 75. Global AT1 Receptor Antagonists Sales by Regions (2015-2020) (K Units)
Table 76. Global AT1 Receptor Antagonists Sales Market Share by Regions (2015-2020)
Table 77. Global AT1 Receptor Antagonists Revenue by Regions (2015-2020) (USD Million)
Table 78. North America AT1 Receptor Antagonists Sales by Countries (2015-2020) (K Units)
Table 79. North America AT1 Receptor Antagonists Sales Market Share by Countries (2015-2020)
Table 80. North America AT1 Receptor Antagonists Revenue by Countries (2015-2020) (USD Million)
Table 81. North America AT1 Receptor Antagonists Revenue Market Share by Countries (2015-2020)
Table 82. Europe AT1 Receptor Antagonists Sales by Countries (2015-2020) (K Units)
Table 83. Europe AT1 Receptor Antagonists Sales Market Share by Countries (2015-2020)
Table 84. Europe AT1 Receptor Antagonists Revenue by Countries (2015-2020) (USD Million)
Table 85. Asia-Pacific AT1 Receptor Antagonists Sales by Regions (2015-2020) (K Units)
Table 86. Asia-Pacific AT1 Receptor Antagonists Sales Market Share by Regions (2015-2020)
Table 87. Asia-Pacific AT1 Receptor Antagonists Revenue by Regions (2015-2020) (USD Million)
Table 88. South America AT1 Receptor Antagonists Sales by Countries (2015-2020) (K Units)
Table 89. South America AT1 Receptor Antagonists Sales Market Share by Countries (2015-2020)
Table 90. South America AT1 Receptor Antagonists Revenue by Countries (2015-2020) (USD Million)
Table 91. South America AT1 Receptor Antagonists Revenue Market Share by Countries (2015-2020)
Table 92. Middle East & Africa AT1 Receptor Antagonists Sales by Countries (2015-2020) (K Units)
Table 93. Middle East & Africa AT1 Receptor Antagonists Sales Market Share by Countries (2015-2020)
Table 94. Middle East & Africa AT1 Receptor Antagonists Revenue by Countries (2015-2020) (USD Million)
Table 95. Middle East & Africa AT1 Receptor Antagonists Revenue Market Share by Countries (2015-2020)
Table 96. Global AT1 Receptor Antagonists Sales by Type (2015-2020) (K Units)
Table 97. Global AT1 Receptor Antagonists Sales Share by Type (2015-2020)
Table 98. Global AT1 Receptor Antagonists Revenue by Type (2015-2020) (USD Million)
Table 99. Global AT1 Receptor Antagonists Revenue Share by Type (2015-2020)
Table 100. Global AT1 Receptor Antagonists Sales by Application (2015-2020) (K Units)
Table 101. Global AT1 Receptor Antagonists Sales Share by Application (2015-2020)
Table 102. Global AT1 Receptor Antagonists Sales Forecast by Regions (2021-2025) (K Units)
Table 103. Global AT1 Receptor Antagonists Market Share Forecast by Regions (2021-2025)
Table 104. Global AT1 Receptor Antagonists Sales Forecast by Type (2021-2025) (K Units)
Table 105. Global AT1 Receptor Antagonists Market Share Forecast by Type (2021-2025)
Table 106. Global AT1 Receptor Antagonists Sales Forecast by Application (2021-2025)
Table 107. Global AT1 Receptor Antagonists Market Share Forecast by Application (2021-2025)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Distributors/Traders/ Dealers List
List of Figures
Figure 1. AT1 Receptor Antagonists Picture
Figure 2. Global Sales Market Share of AT1 Receptor Antagonists by Type in 2019
Figure 3. Valsartan Picture
Figure 4. Telmisartan Picture
Figure 5. Losartan Picture
Figure 6. Irbesartan Picture
Figure 7. Azilsartan Picture
Figure 8. Olmesartan Picture
Figure 9. AT1 Receptor Antagonists Sales Market Share by Application in 2018
Figure 10. Hypertension Picture
Figure 11. Cardiovascular Diseases Picture
Figure 12. Kidney Diseases Picture
Figure 13. Other Picture
Figure 14. Global AT1 Receptor Antagonists Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global AT1 Receptor Antagonists Sales Market Share by Manufacturer in 2019
Figure 35. Global AT1 Receptor Antagonists Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 AT1 Receptor Antagonists Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 AT1 Receptor Antagonists Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global AT1 Receptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 40. Global AT1 Receptor Antagonists Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global AT1 Receptor Antagonists Revenue Market Share by Regions (2015-2020)
Figure 42. Global AT1 Receptor Antagonists Revenue Market Share by Regions in 2018
Figure 43. North America AT1 Receptor Antagonists Sales and Growth Rate (2015-2020)
Figure 44. Europe AT1 Receptor Antagonists Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific AT1 Receptor Antagonists Sales and Growth Rate (2015-2020)
Figure 46. South America AT1 Receptor Antagonists Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa AT1 Receptor Antagonists Sales and Growth Rate (2015-2020)
Figure 48. North America AT1 Receptor Antagonists Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America AT1 Receptor Antagonists Sales Market Share by Countries (2015-2020)
Figure 50. North America AT1 Receptor Antagonists Sales Market Share by Countries in 2018
Figure 51. North America AT1 Receptor Antagonists Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America AT1 Receptor Antagonists Revenue Market Share by Countries in 2018
Figure 53. United States AT1 Receptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Canada AT1 Receptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 55. Mexico AT1 Receptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Europe AT1 Receptor Antagonists Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe AT1 Receptor Antagonists Revenue Market Share by Countries (2015-2020)
Figure 58. Europe AT1 Receptor Antagonists Revenue Market Share by Countries in 2019
Figure 59. Germany AT1 Receptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 60. UK AT1 Receptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 61. France AT1 Receptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Russia AT1 Receptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Italy AT1 Receptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Asia-Pacific AT1 Receptor Antagonists Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific AT1 Receptor Antagonists Sales Market Share by Regions 2019
Figure 66. Asia-Pacific AT1 Receptor Antagonists Revenue Market Share by Regions 2019
Figure 67. China AT1 Receptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Japan AT1 Receptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Korea AT1 Receptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 70. India AT1 Receptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Southeast Asia AT1 Receptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 72. South America AT1 Receptor Antagonists Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America AT1 Receptor Antagonists Sales Market Share by Countries in 2019
Figure 74. South America AT1 Receptor Antagonists Revenue Market Share by Countries in 2019
Figure 75. Brazil AT1 Receptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Argentina AT1 Receptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Middle East and Africa AT1 Receptor Antagonists Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa AT1 Receptor Antagonists Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa AT1 Receptor Antagonists Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa AT1 Receptor Antagonists Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia AT1 Receptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Egypt AT1 Receptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Turkey AT1 Receptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 84. South Africa AT1 Receptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 85. Global AT1 Receptor Antagonists Sales and Growth Rate (2021-2025) (K Units)
Figure 86. Global AT1 Receptor Antagonists Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales AT1 Receptor Antagonists Market Forecast (2021-2025) (K Units)
Figure 88. Europe Sales AT1 Receptor Antagonists Market Forecast (2021-2025) (K Units)
Figure 89. Asia-Pacific Sales AT1 Receptor Antagonists Market Forecast (2021-2025) (K Units)
Figure 90. South America Sales AT1 Receptor Antagonists Market Forecast (2021-2025) (K Units)
Figure 91. Middle East & Africa Sales AT1 Receptor Antagonists Market Forecast (2021-2025) (K Units)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
AT1受容体拮抗薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global AT1 Receptor Antagonists market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The AT1 Receptor Antagon…- アンジオテンシン受容体拮抗薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Angiotensin Receptor Antagonists market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Angiotensin …
- アンジオテンシン受容体遮断薬（ARB）の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Angiotensin Receptor Blockers (ARBs) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Angioten…
- スフィンゴシン1-リン酸受容体1の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Sphingosine 1-Phosphate Receptor 1 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain …
- α-アドレナリン受容体拮抗薬の世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The global α-adrenoreceptor Antagonists market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The α-adrenoreceptor…